Literature DB >> 24117707

Social patterning in knowledge following an informed choice invitation for type 2 diabetes screening.

I Kellar1, D Mason.   

Abstract

AIMS: To describe prevalence of knowledge of items specified by the U.K. General Medical Council as required to make an informed choice following an invitation for screening for type 2 diabetes and investigate whether knowledge was socio-economically patterned.
METHODS: A 9-item knowledge questionnaire was employed immediately following an informed choice invitation to type 2 diabetes screening that was piloted with 278 people between 40 and 69 years in the U.K. between February and April 2006.
RESULTS: With the exception of post-diagnosis treatment and the effectiveness of early treatment in preventing long-term problems, information was typically understood correctly. Social patterning was observed: individuals who left full-time education before 19 years of age were less likely to understand the most likely test result, the effectiveness of early treatment in preventing long-term problems or the possible harms of screening.
CONCLUSIONS: Even risk communication materials developed for ease of readability can result in inequity, limiting autonomy in healthcare decisions.
© 2013 The Authors. Diabetic Medicine © 2013 Diabetes UK.

Entities:  

Mesh:

Year:  2013        PMID: 24117707     DOI: 10.1111/dme.12334

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  2 in total

1.  Socioeconomic factors and effect of evidence-based patient information about primary prevention of type 2 diabetes mellitus--are there interactions?

Authors:  Jutta Genz; Burkhard Haastert; Hardy Müller; Frank Verheyen; Dennis Cole; Wolfgang Rathmann; Bettina Nowotny; Michael Roden; Guido Giani; Christian Ohmann; Andrea Icks
Journal:  BMC Res Notes       Date:  2014-08-18

2.  Evaluation of the effects of a diabetes educational program: a randomized clinical trial.

Authors:  Heloísa de Carvalho Torres; Ana Emília Pace; Fernanda Figueredo Chaves; Gustavo Velasquez-Melendez; Ilka Afonso Reis
Journal:  Rev Saude Publica       Date:  2018-02-05       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.